Cesca Therapeutics (KOOL) Sees Unusually-High Trading Volume

Cesca Therapeutics Inc (NASDAQ:KOOL) saw unusually-high trading volume on Tuesday . Approximately 1,194,661 shares changed hands during trading, an increase of 177% from the previous session’s volume of 431,234 shares.The stock last traded at $0.29 and had previously closed at $0.27.

Separately, Zacks Investment Research downgraded shares of Cesca Therapeutics from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 18th.

The company has a current ratio of 1.93, a quick ratio of 0.97 and a debt-to-equity ratio of 0.80. The firm has a market capitalization of $6.29 million, a PE ratio of -0.30 and a beta of -0.68.

Cesca Therapeutics (NASDAQ:KOOL) last posted its quarterly earnings data on Monday, August 13th. The biotechnology company reported $0.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.12) by $0.16. Cesca Therapeutics had a negative net margin of 322.75% and a negative return on equity of 18.05%. The business had revenue of $2.00 million during the quarter, compared to the consensus estimate of $3.00 million. Analysts forecast that Cesca Therapeutics Inc will post 0.1 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “Cesca Therapeutics (KOOL) Sees Unusually-High Trading Volume” was first published by WKRB News and is owned by of WKRB News. If you are viewing this news story on another domain, it was illegally stolen and reposted in violation of international trademark and copyright legislation. The original version of this news story can be read at https://www.wkrb13.com/2018/11/14/cesca-therapeutics-kool-sees-unusually-high-trading-volume.html.

About Cesca Therapeutics (NASDAQ:KOOL)

Cesca Therapeutics Inc develops, commercializes, and markets a range of automated technologies and products for cell-based therapeutics in the United States, China, rest of Asia, Europe, and internationally. The company develops automated blood and bone marrow processing systems that enable the separation, processing, and preservation of cell and tissue therapy products.

Read More: Short Selling Stocks and Day Traders

Receive News & Ratings for Cesca Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cesca Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply